Addiction Research
According to the World Health Organization (WHO), addiction is 'a chronic disease of the central nervous system that is characterized by a loss of control over impulsive behavior that leads to compulsive drug seeking and taking, and to relapses even after months of abstinence'. Addiction is a complex neuroadaptive process, where drugs of abuse alter cellular and molecular aspects of neural function. The brain circuits mediating the various behavioral effects of these drugs are rendered more, or less, responsive to those effects.
Addiction Research Products Targets
- Others (13)
- D4 Receptor (12)
- 5-HT7 Receptor (11)
- 5-HT6 Receptor (14)
- 5-ht5 Receptor (2)
- 5-HT4 Receptor (17)
- NOP Receptor (21)
- Mu-Opioid Receptors (15)
- Kappa Opioid Receptors (14)
- AMPA Receptor (45)
- GABAA-ρ Receptor (8)
- GABAA Receptor (66)
- GPR55 (8)
- CB2 Receptor (6)
- CB1 Receptor (17)
- Nicotinic (α7) Receptor (25)
- Nicotinic (α4β2) Receptor (14)
- D3 Receptor (12)
- NMDA Receptor (87)
- Kainate Receptor (22)
- D2 Receptor (14)
- D1 and D5 Receptor (16)
- Glutamate Transporter (18)
- Dopamine Transporter (20)
- CRF2 Receptor (3)
- CRF1 Receptor (5)
- 5-HT Transporter (30)
- Delta opioid receptor (16)
Products for Addiction Research - Page 49
- Cat.No. Product Name Information/Activity
-
BCC5864
PL 017
83397-56-2
-
BCN6318
Sinomenine HCl
6080-33-7
-
BCC5684
Clocinnamox mesylate
117332-69-1
-
BCC5776
CTAP
103429-32-9
-
BCC5780
CTOP
103429-31-8
-
BCC7425
Cyprodime hydrochloride
118111-54-9
-
BCC6850
β-Funaltrexamine hydrochloride
72786-10-8
-
BCC6710
Naloxonazine dihydrochloride
880759-65-9
-
BCC4161
MCOPPB trihydrochloride
MCOPPB 3Hcl is a nociceptin receptor agonist with pKi of 10.07; weaker activity at other opioid receptors.
-
BCC7177
NNC 63-0532
250685-44-0


